Table 2 |
||||
|
Antimalarial treatments for children with uncomplicated malaria presenting to all health facilities – change of practice between 2004 and 2006 surveys in four districts in Zambia |
||||
| 2004 |
5–9 kg (N = 527) |
≥ 10 kg (N = 394) |
||
|
|
||||
| No (%) |
95% CI* |
No (%) |
95% CI* |
|
|
|
||||
| Artemether-lumefantrine |
6 (1.1) |
0, 2.7 |
42 (10.7) |
5.4, 16.0 |
| Sulphadoxine-pyrimethamine |
422 (80.1) |
73.9, 86.2 |
266 (67.5) |
58.8, 76.2 |
| Quinine |
14 (2.7) |
0.8, 4.5 |
19 (4.8) |
2.0, 7.6 |
| Chloroquine |
1 (0.2) |
0, 0.6 |
0 |
NA |
| No antimalarial prescribed |
84 (15.9) |
10.3, 21.6 |
67 (17.0) |
11.7, 22.3 |
|
|
||||
| 2006 |
5–9 kg (N = 552) |
≥ 10 kg (N = 547) |
||
|
|
||||
| No (%) |
95% CI* |
No (%) |
95% CI* |
|
|
|
||||
| Artemether-lumefantrine |
149 (27.0) |
19.2, 34.8 |
231 (42.2) |
33.8, 50.7 |
| Sulphadoxine-pyrimethamine |
214 (38.8) |
30.9, 46.7 |
151 (27.6) |
19.9, 35.3 |
| Quinine |
26 (4.7) |
1.5, 7.9 |
38 (7.0) |
2.5, 11.4 |
| No antimalarial prescribed |
163 (29.5) |
23.3, 35.8 |
127 (23.2) |
17.9, 28.5 |
|
|
||||
|
* Confidence intervals adjusted for cluster sampling |
||||
|
Zurovac et al. Malaria Journal 2007 6:31 doi:10.1186/1475-2875-6-31 |
||||
